MFA Financial Inc MFA.PR.C

Primary Symbol: MFA Alternate Symbol(s): MFA.PR.B

Real Estate

MFA Financial, Inc. is an internally managed real estate investment trust that invests in and finances residential mortgage assets. The Company’s targeted investments include principally residential whole loans and residential mortgage securities. Its residential whole loans include purchased performing loans, purchased credit deteriorated and purchased non-performing loans. Its residential mortgage securities include agency mortgage-backed securities (MBS), non-agency MBS, credit risk transfer securities, and MSR-related assets, which include term notes backed directly or indirectly by mortgage servicing rights (MSRs). Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The Company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return.

NYSE:MFA - Post by User

MFA Financial Inc

<< Previous

Bullboard Posts

Next >>

Post by GenevaCon Jun 03, 2022 5:43am

151 Views

Post# 34728804

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance

FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.